Clinical Trial Update: Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and effectiveness of collagen cross-linking at irradiances of 9 and 18 mW/cm2 for keratoconus and corneal ectasia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Snippet

Sponsor: Robert Mack, M.D. | Conditions: Keratoconus, Corneal Ectasia | Phase 1 | Status: UNKNOWN